Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: A meta-analysis

Journal of Traditional Chinese Medicine

Volumn 35, Issue 1, 2015, Pages 15-20

  Sun, Qin ^a   Yang, Gangyi ^b   Zhang, Min ^a   Chen, Shu ^a   Chen, Pin ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Flos Abelmoschi Manihot; Meta analysis; Renal insufficiency

Indexed keywords

ALBUMIN; CHINESE DRUG; CREATININE; HUANGSHUKUIHUA; NITROGEN; UNCLASSIFIED DRUG; UREA; HERBACEOUS AGENT;

ARTICLE; CNKI DATABASE; COCHRANE LIBRARY; CREATININE BLOOD LEVEL; DATA BASE; DIABETIC NEPHROPATHY; EMBASE; HUMAN; KIDNEY FUNCTION; MANIHOT; MEDLINE; META ANALYSIS; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL PROTECTION; SYSTEMATIC REVIEW; UREA NITROGEN BLOOD LEVEL; WEB OF SCIENCE; DIABETIC NEPHROPATHIES; DRUG EFFECTS; KIDNEY; PHYTOTHERAPY;

DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; HUMANS; KIDNEY; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84930241070     PISSN: 02552922     EISSN: 2589451X     Source Type: Journal    
DOI: 10.1016/s0254-6272(15)30003-0     Document Type: Article

References (37)

1. He YN. Application of Okra capsule with valsartan in 40 patients with incipient diabetic nephropathy. Yunnan ZhongYi Zhong Yao Za Zhi 2010;31(6):24-25.
2. De Grauw WJ, Van De Lisdonk EH, Van Gerwen WH, et al. Microalbuminuria in patients with Type 2 diabetes mellitus from general practice: course and predictive value. Diabet Med 2001;18(2):139-143.
3. Bloomgarden ZT. American Diabetes Association annual meeting, 1997, and the Teczem Consultant Meeting. Diabetic nephropathy. Diabetes Care 1998;21(2):315-319.
4. Xie ZW. Han La Yin Dui Zhao Zhong Yao Cai Zheng Ming Ci Dian. Beijing: Beijing science and technology Publishing Co., Ltd., 2004:509.
5. Lai X, Liang H, Zhao Y, Wang B. Simultaneous determination of seven active flavonols in the flowers of Abelmoschus manihot by HPLC. J Chromatogr Sci 2009;47(3):206-210.
6. Lai X, Zhao Y, Liang H, Bai Y, Wang B, Guo D. SPE-HPLC method for the determination of four flavonols in rat plasma and urine after oral administration of Abelmoschus manihot extract. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852(1-2):108-114.
7. Zhou L, An XF, Teng SC, et al. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food 2012;15(5):461-468.
8. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983;32(Suppl 2):64-78.
9. Higgins JPT, Altman DG, Sterne JAC (editors) (2011) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
10. Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
11. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration 2011.
12. Bu HX, Xu K, Zhang H. Clinical research about Okra capsule combined with sulodexide in early-stage diabetic nephropathy. Henan Zhi Gong Yi Xue Yuan Xue Bao 2012;24(2):146-147.
13. Cai X, Huang B, Wang Y, Chen Z. Effects of Okra capsule on tubular function in diabetic nephropathy. Dang Dai Yi Xue 2010;16(31):153-154.
14. Chang LL, Yang SL, Zhao XL. Effects of Okra capsule on tubular function in diabetic nephropathy. Shandong Yi Yao 2009;49(39):142-143.
15. Chen Y. The clinical research about therapeutic effect of Okra capsule with telmisartan in diabetic nephropathy. Xian Ning Xue Yuan Xue Bao (Yi Xue Ban) 2010;24(5):411-412.
16. Ding LP, Li XM, Xu C, Zhuo L. Observation the curative effect of alprostadil combined with Okra capsule in diabetic nephropathy IV. Zhong Guo Wu Zhen Xue Za Zhi 2011;11(26):76-77.
17. Guan ZX, Zhang WH. Application of Okra capsule with angiotensin converting enzyme inhibitor in diabetic nephropathy. Shi Yong Yi Ji Za Zhi 2008;15(32):4670-4671.
18. Hu J P, Cao S, Luo F. Clinical research of Okra capsule with telmisartan in early- and intermediate-stage diabetic nephropathy. Zhong Guo Zhong Yao Za Zhi 2011;26(3):353-354.
19. Jiang ZJ. The clinical efficacy of Okra capsule combined with novomix 30 in diabetic nephropathy. Xian Dai Zhen Duan Yu Zhi Liao 2012;23(6):755-756.
20. Li, HY, Xiang F, Wang Q, Li SF. Application of Okra capsule with Fosinopril in diabetic nephropathy IV. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2009;17(8):691-692.
21. Li QH, He JL. Observation of the therapeutic effect of Okra capsule with valsartan on proteinuria in early stage of diabetic nephropathy. Zhong Guo Zhong Xi Yi Jie He Shen Bing Za Zhi 2010;11(2):142-143.
22. Li XH, Lu YM, Liang YE. Application of Okra capsule with Losartan in diabetic nephropathy. Lin Chuang Yi Xue Gong Cheng 2009;16(3):3-4.
23. Li YL. Application of Okra capsule with lotensin in 30 patients with diabetic nephropathy. Shanxi Zhong Yi 2007;28(5):562-563.
24. Liu JF, Jia YP. Application of Okra capsule with candesartan in 48 patients with diabetic nephropathy. You Jiang Yi Xue 2011;39(39):202-203.
25. Liu, KH, Wang L, Zhang Y. The clinical research of Okra in treatment of diabetic nephropathy. Jilin Yi Xue 2005;26(10):1022-1023.
26. Qian CF, Qian H. Application of Okra capsule with valsartan on proteinuria in early stage of diabetic nephropathy. Zhong Guo Shi Yong Yi Yao 2010:5(27):141-142.
27. Shan JP, Ye YX. Observation of the clinical effect of Okra capsule with glutathione in diabetic nephropathy. Zhong Guo Lao Nian Xue Za Zhi 2010;30(16):2374-2375.
28. Shen LL, Shen Y, Fang XX, Qiu ZL. The effect of Okra capsule on incipient diabetic nephropathy. Shandong Yi Yao 2010;50(43):59-60.
29. Shen XH, Wang H, Xu SX, Tao J. Application of Okra capsule with telmisartan in early-stage diabetic nephropathy. Yi Xue Xin Xi 2011;24(1):228-229.
30. Song XL. Benazepril hydrochloride tablets combined with ambrette capsule for the treatment of type 2 diabetic nephropathy proteinuria. Yi Xue Li Lun Yu Shi Jian 2012;25(18):2238-2239.
31. Su JP, Xu J, Zhai XL, Zhang X, Cheng BZ, Lu X. The effect of Okra capsule on renal function of diabetic nephropathy, as well as plasma laminin and hyaluronic acid. Zhong Guo Lin Chuang Yi Sheng 2009;37(12):48-50.
32. Su Y, Zhang DC, Zhong S. Observation of the clinical effect of Okra capsule with Salvia miltiorrhiza and Ligustrazine in diabetic nephropathy. Zhong Guo Zhong Xi Yi Jie He Shen Bing Za Zhi 2010;11(2):1112.
33. Sun XM, Bai J, Zhao L. Observation of Okra capsule combined with routine treatment in diabetic nephropathy. Shanghai Zhong Yi Yao Za Zhi 2012;46(7):54-55.
34. Xiao ZZ, Sun HJ. The effect of Okra capsule with valsartan on microalbuminuria in early stage of diabetic nephropathy. Xiari Dai Zhong Xi Yi Jie He Za Zhi 2010;19(3):263-264.
35. Yang S, Liu XH. Application of Okra capsule with western medicine in early stage of diabetic nephropathy. Hebei Zhong Yi 2009;31(4):600-602.
36. Yu CJ, Wang XS. Observation of the clinical effect of Okra capsule in early stage of diabetic nephropathy. Zhong Guo Zhong Yi Ji Zheng 2010;19(10):1685, 1709.
37. Zhao JW, Zheng YW, Ji Q, Zhai, XL. Effect of Okra capsule combined with benazepril in diabetic nephropathy, a case-control study. Zhong Guo Xian Dai Yi Xue Za Zhi 2011;21:2412-2414.